When injected into mouse models of Alzheimer's disease, two short peptides significantly improved memory, reduced inflammation, and lowered amyloid plaque buildup in the brain.
Reduced levels of an amino acid called betaine is associated with schizophrenia pathology. Supplementing betaine levels improved cognitive and behavioral deficits in mouse models of schizophrenia. The amino acid also reduced oxidative stress at the molecular level.
Researchers say the sight and smell of food alone may be enough to prompt the liver to start the processes that help digest food.
A new study considers how early nutrition can affect a baby's brain development.
A new study reports peptides related to Alzheimer's disease wiggle at dangerously fast speeds prior to forming amyloid plaques.
A new study reports Alzheimer's disease impairs insulin signalling in the hypothalamus, making it more likely that a person with Alzheimer's to develop diabetes.
Administering a cocktail of amino acids to mice models of TBI, researchers improved sleep disturbances caused by the brain injuries.
Using a new optogenetic technique, researchers change the shape of a protein in the brains of mice.
Using sophisticated imaging techniques, researchers observe a molecular protein folding process which could help better understand and treat neurodegenerative diseases and cancers.
Researchers discover an enzyme, IDH, which facilitates the breakdown of specific amino acids makes glioblastoma brain cancer particularly aggressive.
